{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:54:26Z","timestamp":1791888866613,"version":"4.3.4"},"reference-count":38,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,10,15]],"date-time":"2009-10-15T00:00:00Z","timestamp":1255564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> Parathyroid hormone increases the differentiation of osteoblast precursors through canonical wingless (Wnt) signalling, resulting in an osteoanabolic effect. We aimed to evaluate serum levels of the Wnt\u2010inhibitor Dickkopf\u20101 (Dkk\u20101) in postmenopausal women with established osteoporosis and their changes with teriparatide (TPTD \u2013 human recombinant PTH 1\u201334).<\/jats:p><jats:p><jats:bold>Design and patients\u2002<\/jats:bold> A total of 31 postmenopausal Caucasian women with established osteoporosis (mean age 66\u00b73\u2003\u00b1\u20031\u00b74\u2003years) received daily injections of 20\u2003\u03bcg TPTD for 18\u2003months. Follow\u2010up was continued for another 6\u2003months after treatment discontinuation (total duration of treatment 24\u2003months).<\/jats:p><jats:p><jats:bold>Measurements\u2002<\/jats:bold> Serum samples for total calcium (Ca), intact PTH (iPTH), bone\u2010specific alkaline phosphatase, C\u2010terminal cross\u2010linking telopeptide of type 1 collagen (CTx) and Dkk\u20101 were obtained at baseline, and at 6, 18 and 24\u2003months after TPTD initiation. Lumbar spine bone mineral density (BMD) was measured before and after 18\u2003months of TPTD treatment. A total of 16 age\u2010 and gender\u2010matched healthy controls were also analysed at baseline.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Serum Dkk\u20101 levels at baseline were significantly higher in osteoporotic women compared with that in controls (<jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0\u00b7002). Dkk\u20101 increased significantly during TPTD administration (<jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0\u00b7044) and decreased to baseline 6\u2003months after TPTD discontinuation. Dkk\u20101 change was positively correlated to Ca (<jats:italic>r\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0\u00b7530, <jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0\u00b7004) and negatively correlated to iPTH change (<jats:italic>r<\/jats:italic>\u2003=\u2003\u22120\u00b7398, <jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0\u00b7040). There was no correlation between Dkk\u20101 and BMD changes.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Our data suggest that Dkk\u20101 levels are increased in women with postmenopausal osteoporosis. TPTD therapy results in further increase of Dkk\u20101 that may be compensative to TPTD\u2010induced enhanced Wnt signalling.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2009.03728.x","type":"journal-article","created":{"date-parts":[[2009,10,15]],"date-time":"2009-10-15T08:09:51Z","timestamp":1255594191000},"page":"752-757","source":"Crossref","is-referenced-by-count":49,"title":["The effect of teriparatide on serum Dickkopf\u20101 levels in postmenopausal women with established osteoporosis"],"prefix":"10.1111","volume":"72","author":[{"given":"Athanasios D.","family":"Anastasilakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avraam","family":"Avramidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos A.","family":"Toulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Papatheodorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,5,18]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68891-0"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.21840"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2004-0006"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020334"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/clinchem\/42.2.210","article-title":"Method for determination of bone alkaline phosphatase activity;analytical performance and clinical usefulness in patients with metabolic and malignant bone diseases","volume":"42","author":"Withold W.","year":"1996","journal-title":"Clinical Chemistry"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105103441904"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-1703"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2006.02.003"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2008.01768.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2002-0023"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1334.010"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra067395"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.10.1842"},{"key":"e_1_2_6_15_2","first-page":"S368","article-title":"Beta\u2010catenin signaling during osteoblast differentiation","volume":"16","author":"Sheikh S.S.","year":"2001","journal-title":"Journal of Bone and Mineral Research"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2007.12.006"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.050614"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-6-71"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22867"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604069"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2008.01065.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603959"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-009-9225-y"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2008.000893"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K07E-123"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28551"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.21626"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-0910"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2006.09.004"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404843"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.051276"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(00)00410-5"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2005.03.018"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0239"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.20834"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M212226200"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.061002"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0528"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgm094"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2009.03728.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2009.03728.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:35:48Z","timestamp":1697441748000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2009.03728.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,18]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1111\/j.1365-2265.2009.03728.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03728.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,18]]}}}